LY 171555

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Almost no information is available concerning the link between clinical effects of dopamine D2 receptor agonists in the treatment… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Several experiments investigated the involvement of D1 and D2 dopamine receptors in the ventral striatum in the control over… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The effect of tetanic activation of corticostriatal glutamatergic fibers was studied in striatal slices by utilizing… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1991
1991
Recent radioligand binding studies demonstrated an increase in the density of dopamine D2 receptors in the nucleus accumbens… (More)
Is this relevant?
1990
1990
The D2 dopamine receptor agonist LY 171555 (0.5 to 5 mg/kg) induces dose-dependent catalepsy in C57BL/6, DBA/2 and BALB/c inbred… (More)
Is this relevant?
1989
1989
Pharmacological blockade of either nicotinic or muscarinic cholinergic receptors has been found to impair choice accuracy in the… (More)
Is this relevant?
1989
1989
The selective D2 dopamine receptor agonist LY 171555 increased defensive behavior dose dependently, decreased social… (More)
  • table 1
Is this relevant?
1989
1989
The behavioural effects of the D-1 agonist SKF 38393 (0.56-45 mg/kg) and the D-2 agonist LY 171555 (0.05-6.25 mg/kg) were studied… (More)
Is this relevant?
1988
1988
Dose-effect curves were obtained for five specific components of stereotyped behavior (locomotor hyperactivity, rearing, sniffing… (More)
Is this relevant?
1988
1988
Administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to common marmosets induced persistent motor deficits… (More)
Is this relevant?